NASDAQ Composite opens in less than one hour and Catalyst Pharmaceuticals’s pre-market value is already 2.44% up.

The last session, NASDAQ Composite ended with Catalyst Pharmaceuticals jumping 3.07% to $3.69. NASDAQ Composite jumped 1.97% to $13,457.25, after two successive sessions in a row of gains, on what was an all-around positive trend trading session.

Catalyst Pharmaceuticals’s last close was $3.69, 43.09% below its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the present quarter and 5.5% for the next. The company’s growth estimates for the present quarter is 12.5% and a drop 20% for the next.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was 3.07%, 0.84%, and 0.02%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 6.76%, 4.24%, and 4.37%, respectively.

LEAVE A REPLY

Please enter your comment!
Please enter your name here